TB survivors enroll in study to predict recurrence

NCT ID NCT07018076

Recruiting now Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study looks at 750 people who have finished treatment for drug-sensitive tuberculosis. Researchers will test new sputum and blood-based methods to see if they can predict whether the disease will come back within a year. The goal is to find better ways to measure treatment success and improve future TB clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better tools for predicting TB recurrence, making future treatment trials faster and more reliable.
What could go wrong: This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough to change clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS

Contacts and locations

Locations

Hanoi Lung Hospital, Outpatient departments
NOT_YET_RECRUITING

Hanoi, Vietnam
Kisenyi Health Center
RECRUITING

Kampala, Uganda
Mulago Outpatient Department
RECRUITING

Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.